Login to Your Account



China to Establish Regulatory Biosimilars Framework

By Shannon Ellis
Staff Writer

Wednesday, August 28, 2013
SHANGHAI – Looking to lower costs and facilitate better health care outcomes, China is stepping up efforts to develop a regulatory framework and a market for biosimilars.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription